Literature DB >> 29196344

Differential cardiac hypertrophy and signaling pathways in pressure versus volume overload.

Jieyun You1, Jian Wu2, Qi Zhang3, Yong Ye2, Shijun Wang2, Jiayuan Huang2, Haibo Liu3, Xiaoyan Wang2, Weijing Zhang2, Liping Bu2, Jiming Li3, Li Lin3, Junbo Ge2, Yunzeng Zou2.   

Abstract

Mechanical overload can be classified into pressure overload and volume overload, causing concentric and eccentric cardiac hypertrophy, respectively. Here, we aimed to differentiate the load-mediated signaling pathways involved in pressure versus volume overload cardiac hypertrophy. Pressure or volume overload was imposed on C57BL/6J mice by transverse aortic constriction (TAC) or aortic regurgitation (AR), respectively. After surgery (2 wk), left ventricular structure and function were evaluated by echocardiographic, hemodynamic, and histological analyses. Signaling pathways related to hypertrophy, fibrosis, angiogenesis, and apoptosis were studied by histological analysis, RT-PCR, and Western blot analysis. Although mean wall stress was similar in both TAC and AR mice, systolic wall stress was significantly increased in TAC and diastolic wall stress was mainly elevated in AR. TAC or AR induced concentric or eccentric compensated hypertrophy, respectively. TAC was associated with more significant fibrosis and apoptosis, whereas AR was associated with more significant angiogenesis. MAPK kinase family, β-arrestin-2, Akt, and Ca2+-related signaling pathways were markedly activated in TAC but mildly upregulated or unchanged in AR. Pressure overload and volume overload induce different phenotypic and molecular adaptations in cardiac hypertrophy. Most load-related signaling pathways assessed in this study predominate in pressure but not volume overload. The stimulus-specific heterogeneity in the signaling pathways requires distinct manipulations for further mechanistic and pharmacological studies. NEW & NOTEWORTHY Using the transverse aortic constriction mouse model and the newly developed aortic regurgitation mouse model, we delineated the prominent differences between concentric and eccentric cardiac hypertrophy on morphological, functional, and molecular levels. Our findings are important for the precise diagnosis and treatment of these two types of cardiac hypertrophy. Listen to this article's corresponding podcast at http://ajpheart.podbean.com/e/chinese-english-language-podcast-on-differential-cardiac-remodeling-in-tac-vs-ar/ .

Entities:  

Keywords:  aortic regurgitation; cardiac hypertrophy; pressure overload; transverse aortic constriction; volume overload

Mesh:

Year:  2017        PMID: 29196344     DOI: 10.1152/ajpheart.00212.2017

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  26 in total

1.  Estrogen receptor-α prevents right ventricular diastolic dysfunction and fibrosis in female rats.

Authors:  Tik-Chee Cheng; Jennifer L Philip; Diana M Tabima; Santosh Kumari; Bakhtiyor Yakubov; Andrea L Frump; Timothy A Hacker; Alessandro Bellofiore; Rongbo Li; Xin Sun; Kara N Goss; Tim Lahm; Naomi C Chesler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-10-16       Impact factor: 4.733

Review 2.  Hemodynamic assessment of diastolic function for experimental models.

Authors:  Leslie M Ogilvie; Brittany A Edgett; Jason S Huber; Mathew J Platt; Hermann J Eberl; Sohrab Lutchmedial; Keith R Brunt; Jeremy A Simpson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-03-27       Impact factor: 4.733

Review 3.  Gender Differences in Cardiac Hypertrophy.

Authors:  Jian Wu; Fangjie Dai; Chang Li; Yunzeng Zou
Journal:  J Cardiovasc Transl Res       Date:  2019-08-15       Impact factor: 4.132

4.  A New Minimally Invasive Method of Transverse Aortic Constriction in Mice.

Authors:  Huayang Li; Quan Liu; Shunjun Wang; Lin Huang; Suiqing Huang; Yuan Yue; Kangni Feng; Zhongkai Wu
Journal:  J Cardiovasc Transl Res       Date:  2021-09-08       Impact factor: 3.216

5.  Involvement of Endoplasmic Reticulum Stress-Mediated Activation of C/EBP Homologous Protein in Aortic Regurgitation-Induced Cardiac Remodeling in Mice.

Authors:  Xingxu Wang; Wei Wei; Jian Wu; Le Kang; Shuangquan Wu; Jiming Li; Yunli Shen; Jieyun You; Yong Ye; Qi Zhang; Yunzeng Zou
Journal:  J Cardiovasc Transl Res       Date:  2021-08-23       Impact factor: 3.216

Review 6.  SUMOylation targeting mitophagy in cardiovascular diseases.

Authors:  Hong Xiao; Hong Zhou; Gaofeng Zeng; Zhenjiang Mao; Junfa Zeng; Anbo Gao
Journal:  J Mol Med (Berl)       Date:  2022-09-26       Impact factor: 5.606

7.  Ca2+/calmodulin-dependent protein kinase II and protein kinase G oxidation contributes to impaired sarcomeric proteins in hypertrophy model.

Authors:  Kamilla Gömöri; Melissa Herwig; Heidi Budde; Roua Hassoun; Nusratul Mostafi; Saltanat Zhazykbayeva; Marcel Sieme; Suvasini Modi; Tamara Szabados; Judit Pipis; Nikolett Farkas-Morvay; István Leprán; Gergely Ágoston; István Baczkó; Árpád Kovács; Andreas Mügge; Péter Ferdinandy; Anikó Görbe; Péter Bencsik; Nazha Hamdani
Journal:  ESC Heart Fail       Date:  2022-05-18

Review 8.  Computational models of cardiac hypertrophy.

Authors:  Kyoko Yoshida; Jeffrey W Holmes
Journal:  Prog Biophys Mol Biol       Date:  2020-07-21       Impact factor: 3.667

Review 9.  Experimental models of cardiac physiology and pathology.

Authors:  Jae Gyun Oh; Changwon Kho; Roger J Hajjar; Kiyotake Ishikawa
Journal:  Heart Fail Rev       Date:  2019-07       Impact factor: 4.214

10.  Cardiovascular magnetic resonance demonstrates structural cardiac changes following transjugular intrahepatic portosystemic shunt.

Authors:  Ulf K Radunski; Johannes Kluwe; Malte Klein; Antonio Galante; Gunnar K Lund; Christoph Sinning; Sebastian Bohnen; Enver Tahir; Jitka Starekova; Peter Bannas; Christian Stehning; Gerhard Adam; Ansgar W Lohse; Stefan Blankenberg; Kai Muellerleile; Daniel Benten
Journal:  Sci Rep       Date:  2021-06-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.